Header Logo

Connection

GEORGE R BLUMENSCHEIN to Sensation Disorders

Back to Details
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Sensation Disorders.
GEORGE R BLUMENSCHEIN
Connection Strength
0.036
Sensation Disorders
  1. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1104-1115.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.